Arca
Skip to content

Brain injury

Drug research and approvals for brain injury: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 839 studies of brain injury are recruiting on ClinicalTrials.gov, Health Canada has authorized 18 drug trials for it since 2013, and FDA has 0 approved and 5 open orphan designations naming it.

  • Recruiting worldwide: 839
  • Trials authorized in Canada: 18
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 839 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

The 10 newest of 18; search them all in Canada trials
Aug 15, 2025Brainapt – tbi international adaptative platform trialMETOPROLOL / PROPRANOLOL / PHENYTOIN / LEVETIRACETAMCHU DE QUÉBEC-UNIVERSITÉ LAVALOngoing
Aug 15, 2025A randomized, double-blind, placebo-controlled phase 2 exploratory study to evaluate the neuroprotective effects of av-001 on hemodialysis-induced brain injury…AV-001VASOMUNE THERAPEUTICS, INC.Ongoing
Oct 10, 2024Psilocybin-assisted therapy for chronic traumatic brain injuryPSILOCYBINROOTS TO THRIVEPending
Jul 26, 2024Frozen plasma in acute traumatic brain injury randomized controlled trial (f-tbi)FROZEN PLASMASUNNYBROOK RESEARCH INSTITUTEPending
Dec 20, 2023Beta blockers in traumatic brain injury (betrr)PROPRANOLOLLONDON HEALTH SCIENCES CENTREPending
Sep 26, 2023Effects of dexmedetomidine on agitation in critically ill tbi patients (dex-tbi)DEXMEDETOMIDINECIUSSS DU NORD-DE-L'ILE-DE-MONTRÉAL - HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL.Ongoing
Feb 2, 2023Treatment of neonatal encephalopathy with oral sildenafil suspension to repair brain injury secondary to birth asphyxia: a randomized, double-blind,…SILDENAFILRESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTREOngoing
Aug 11, 2022A phase I safety and feasibility study of metformin in infants after perinatal brain injuryMETFORMINTHE HOSPITAL FOR SICK CHILDRENClosed
May 22, 2019Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of nt 201 in the treatment of lower limb…XEOMIN (NT 201)Merz GroupClosed
May 8, 2019Treatment of neonatal encephalopathy with oral sildenafil suspension to repair brain injury secondary to birth asphyxia: an open-label dose-finding clinical…SILDENAFILMONTREAL CHILDRENS HOSPITALOngoing

FDA Orphan Designations

Approved first, then open designations, newest first
Jul 24, 2012autologous umbilical cord bloodTreatment of pediatric (0-16 yrs old inclusive) cerebral palsy due to acquired brain injuryDuke UniversityDesignated
Nov 23, 2010cyclosporine; ciclosporinTreatment of moderate to severe traumatic brain injury.Owl TherapeuticsDesignated
May 23, 2006Apomorphine hydrochlorideFor the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain…NeuroHealing Pharmaceuticals, Inc.Designated
Apr 15, 2005AnatibantTreatment of patients having experienced a severe traumatic brain injury (Glasgow Coma Scale 3 to 8) in order to decrease early mortality…Xytis, Inc.Designated
Aug 11, 2004dexanabinolFor the attenuation or amelioration of the long-term neurological sequelae associated with moderate and severe traumatic brain injuryPharmos CorporationDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.